Evaluation of melatonin treatment in primary culture of canine mammary tumors

Nenhuma Miniatura disponível

Data

2015-01-01

Autores

Lopes, Juliana Ramos [UNESP]
Maschio, Larissa Bazela [UNESP]
Jardim-Perassi, Bruna Victorasso [UNESP]
Moschetta, Marina Gobbe
Ferreira, Livia Carvalho [UNESP]
Martins, Gustavo Rodrigues
Gelaleti, Gabriela Bottaro [UNESP]
Zuccari, Debora Aparecida Pires de Campos [UNESP]

Título da Revista

ISSN da Revista

Título de Volume

Editor

Spandidos Publ Ltd

Resumo

Mammary neoplasias are the most common tumors observed in female dogs. Identification of these tumors is valuable in order to identify beneficial therapeutic agents as alternative treatments for this tumor type. Oral administration of melatonin appears to exert an oncostatic effect on mammary neoplasia and may have a possible mechanism of action through its interaction with estrogen receptors on epithelial cells. Hence, we analyzed the potential therapeutic value of melatonin in tumors that are estrogen-dependent or -independent, and established a relationship of its action with the expression of the melatonin receptors MT1 and MT2. Furthermore, we analyzed the rate of cell proliferation and apoptosis after treatment with melatonin. Cell cultures were performed using 10 canine mammary tumor fragments and were divided into estrogen receptor (ER)-positive and ER-negative tumors. The results showed that both ER-positive and ER-negative tumors had decreased cell viability and proliferation after treatment with melatonin (p<0.05), although treatment was more effective in the ER-positive tumors. Analysis of the relative expression of the MT1 and MT2 genes by quantitative PCR was performed and the data were compared with the expression of ER in 24 canine mammary tumors and the cellular response to melatonin in 10 samples. MT1 was overexpressed in ER-positive tumors (p<0.05), whereas MT2 was not expressed. Furthermore, melatonin treatment in ER-positive tumors showed an efficient oncostatic effect by inhibiting cell viability and proliferation and inducing apoptosis. These results suggest that melatonin decreased neoplastic mammary cell proliferation and viability and induced apoptosis, with greater efficacy in ER-positive tumors that have a high expression of melatonin receptor MT1. This is a strong evidence for the use of melatonin as a therapeutic agent for estrogen-dependent canine mammary tumors.

Descrição

Palavras-chave

melatonin, estrogen receptor, immunocytochemistry, MT1, MT2

Como citar

Oncology Reports. Athens: Spandidos Publ Ltd, v. 33, n. 1, p. 311-319, 2015.

Coleções